pharmacovigilance

There is a very effective safety net in the field of pharmacovigilance.

This problem cannot always be prevented by pharmacovigilance, even though it is very important.

The link between the pharmaceutical industry in Europe and pharmacovigilance is yet again at the heart of the debate.

He works as monitor of clinical trials and pharmacovigilance technician.

Strengthening pharmacovigilance has therefore been one of our priorities.

Introduction of biosimilars also requires a specifically designed pharmacovigilance plan.

To collaborate with member countries in the development and practice of the science of pharmacovigilance.

Here the G10 put the need for stronger systems of pharmacovigilance and relative effectiveness firmly on the agenda.

It should be remembered that such cooperation must also work in other areas, such as pharmacovigilance.

Several organisations play a key collaborative role in the global oversight of Pharmacovigilance:

So it is vitally important that we have a simplified, more reliable package on pharmacovigilance too.

Drug regulatory authorities also play a key role in the national or regional oversight of Pharmacovigilance:

Clinical pharmacy services provided to the hospitals include pharmaceutical care, drug information, pharmacovigilance and poisoning management.

However, it was agreed that the committee's pharmacovigilance working party would investigate if there was a safety issue with this compound.

Most Latin American countries have high or medium levels of regulatory pharmacovigilance requirements, in line with international standards.

Adverse reaction reporting is an important component of New Zealand's pharmacovigilance activities.

Pharmacovigilance is conducted by spontaneous reporting systems through health care professionals and others which report adverse drug reactions to the central agency.

Far from running counter to the new provisions on pharmacovigilance, this measure clearly strengthens the safety of medicinal products.

I have to say that, in the case of medicines, this is already covered by the pharmacovigilance legislation that we are proposing.

We believe that this rule helps pharmacies carry out their difficult role in pharmacovigilance and education on the correct use of medicinal products.

This is especially important because a well-functioning pharmacovigilance system is essential for patients’ wellbeing.

I have instructed my services to conduct a stress test now, including on the new pharmacovigilance processes and procedures put in place after our last agreement.

In effect, that is why, over time, we feel that we should be strengthening our pharmacovigilance processes and procedures.

There are also some areas that are altogether unique to pharmacoepidemiology, e.g., pharmacovigilance.

One of the most important, and challenging, problems in pharmacovigilance is that of the determination of causality.